Medical Device News Magazine

EVEON Accelerates its Developments and Expands its Range of Medical Devices

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

EVEON positions itself as a key player to make easily accessible new molecules, particularly biologics, to the largest number of people.

EVEON also enables administration methods that make life easier for patients by contributing to new care pathways. The challenges induced by healthcare reimbursement systems can be reduced by medical devices more innovative and adapted for patients and healthcare professionals.

EVEON focuses on the design, development and industrialization, with its partners of the JBT HubUp alliance, of upgraded medical devices for both drug preparation and drug delivery. EVEON offers tailor-made solutions for applications at home or in a medical environment, based on a unique technology platform Intuity®. Safety and ease of use are the basis of its developments.

In 2019, EVEON produced the first functional models of Intuity® Ject, reaching a new stage in its development and growth. Different versions of this device are being prepared for reconstitution and injection of drugs. EVEON has also developed, based on its patented technologies, a new automated medical spray device, Intuity® Spray, for the delivery of high viscosity treatments through the respiratory, dermatological or oral routes. These devices are in addition to the Intuity® Mix device that allows the automatic reconstitution of lyophilized drugs.

At the end of 2019, Forbes magazine ranked EVEON 3rd most inventive company in France in the medical technologies category.

“In 2019, with the confidence of our customers and the mobilization of our teams and partners, we have reached new milestones and accelerated our developments. Thanks to these innovations, we are already planning new evolutions in 2020 for EVEON both in terms of technology and of overall performance,” said Vincent TEMPELAERE, CEO of EVEON.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”